Table 5.

Final diagnosis according to multidisciplinary discussion.

	n (%)
Fibrotic hypersensitivity pneumonitis	11 (14.7)
Idiopathic pulmonary fibrosis	9 (12.0)
Respiratory-bronchiolitis interstitial lung disease	8 (10.7)
Sarcoidosis	8 (10.7)
Unclassifiable DPLD	7 (9.3)
Non-specific interstitial lung disease	6 (8.0)
Rheumatoid-arthritis interstitial lung disease	6 (8.0)
Connective tissue interstitial lung disease	5 (6.6)
Cryptogen organizing pneumonia	4 (5.3)
Alveolary lung carcinoma (adenocarcinoma)	3 (4.0)
Desquamative interstitial pneumonia	2 (2.6)
Nonfibrotic hypersensitivity pneumonitis	1 (1.3)
Langerhans cell hystiocytosis	1 (1.3)
Eosinophilic granulomatosis with polyangiitis	1 (1.3)
Radiation-induced organizing pneumonia	1 (1.3)
Drug-induced ILD (Amiodaron)	1 (1.3)
Behcet’s disease	1 (1.3)

DPLD, diffuse parenchymal lung disease; ILD, interstitial lung disease.

Percentages may not total 100% because of rounding.